TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | -2.21%6.95B | 14.35%13.33B | 25.91%7.11B | -21.44%11.66B | -28.59%5.65B | 11.32%14.84B | 29.52%7.91B | 21.74%13.33B | 0.89%6.1B | 0.62%10.95B |
Profit adjustment | ||||||||||
Interest (income) - adjustment | 2.32%-2.4B | -156.81%-4.83B | -320.38%-2.46B | -145.43%-1.88B | -33.64%-584M | 56.80%-766M | 56.90%-437M | 8.84%-1.77B | -3.68%-1.01B | -14.14%-1.95B |
Attributable subsidiary (profit) loss | -23.08%-48M | -15.49%-82M | 7.14%-39M | 11.25%-71M | -10.53%-42M | -15.94%-80M | 2.56%-38M | -115.63%-69M | ---39M | -1,500.00%-32M |
Impairment and provisions: | ---- | ---- | ---- | ---- | ---- | -41.67%7M | ---- | 33.33%12M | ---- | 800.00%9M |
-Impairment of trade receivables (reversal) | ---- | ---- | ---- | ---- | ---- | -41.67%7M | ---- | 33.33%12M | ---- | 800.00%9M |
Revaluation surplus: | 40.30%-120M | -123.67%-120M | -138.43%-201M | 204.54%507M | 260.92%523M | 0.41%-485M | -335.51%-325M | 38.28%-487M | 125.79%138M | -844.34%-789M |
-Other fair value changes | 40.30%-120M | -123.67%-120M | -138.43%-201M | 204.54%507M | 260.92%523M | 0.41%-485M | -335.51%-325M | 38.28%-487M | 125.79%138M | -844.34%-789M |
Depreciation and amortization: | -2.92%698M | -1.10%1.44B | 0.28%719M | 7.75%1.46B | 8.31%717M | 13.12%1.35B | 21.47%662M | 14.66%1.2B | 10.10%545M | 37.01%1.04B |
-Depreciation | -2.92%698M | -1.10%1.44B | 0.28%719M | 7.75%1.46B | 8.31%717M | 13.12%1.35B | 21.47%662M | 14.66%1.2B | 10.10%545M | 37.01%1.04B |
Financial expense | -15.71%59M | -2.17%135M | -4.11%70M | -10.39%138M | -98.35%73M | -14.92%154M | -74.13%4.43B | 2.26%181M | 19,804.65%17.12B | 55.26%177M |
Special items | -3,925.00%-153M | 20.49%394M | -98.92%4M | 16.37%327M | 109.25%369M | -4.10%281M | 76.51%-3.99B | 19.11%293M | -11,347.02%-16.98B | 9.82%246M |
Operating profit before the change of operating capital | -4.17%4.99B | -15.36%10.27B | -22.31%5.21B | -20.69%12.14B | -18.35%6.7B | 20.65%15.31B | 39.85%8.21B | 31.31%12.69B | 11.24%5.87B | -6.96%9.66B |
Change of operating capital | ||||||||||
Accounts receivable (increase)decrease | ---- | -269.05%-8.23B | ---- | -68.36%4.87B | ---- | 203.27%15.39B | ---- | -171.97%-14.9B | ---- | -678.27%-5.48B |
prepayments (increase)decrease | ---- | -98.31%77M | ---- | 493.28%4.56B | ---- | 75.59%-1.16B | ---- | -405.79%-4.75B | ---- | 217.28%1.55B |
Financial assets at fair value (increase)decrease | -183.33%-155M | -89.12%206M | 106.67%186M | 221.64%1.89B | 106.21%90M | -155.35%-1.56B | -166.24%-1.45B | 360.22%2.81B | 221.88%2.19B | -15.49%-1.08B |
Special items for working capital changes | ---- | 184.69%8.14B | ---- | 32.42%-9.61B | ---- | -172.81%-14.22B | ---- | 389.37%19.53B | ---- | 129.18%3.99B |
Cash from business operations | 8.47%5.85B | -13.54%11.29B | -20.40%5.4B | -14.73%13.06B | -15.59%6.78B | 28.13%15.32B | 58.23%8.03B | 7.30%11.96B | -13.69%5.08B | 6.98%11.14B |
Other taxs | 58.48%-805M | -413.41%-2.95B | -331.85%-1.94B | 73.30%-574M | 24.41%-449M | 7.33%-2.15B | 66.55%-594M | -438.28%-2.32B | -451.55%-1.78B | 67.42%-431M |
Interest received - operating | -8.84%4.76B | 153.50%10B | 610.88%5.23B | 408.90%3.94B | 67.81%735M | -62.49%775M | -66.59%438M | -33.27%2.07B | -15.36%1.31B | 14.08%3.1B |
Interest paid - operating | 2.68%-3.02B | -164.77%-6.01B | -1,375.24%-3.1B | -4,731.91%-2.27B | -854.55%-210M | 86.53%-47M | 93.31%-22M | 72.04%-349M | 47.19%-329M | -16.53%-1.25B |
Special items of business | -54,800.00%-1.1B | -204.65%-832M | -114.29%-2M | 151.06%795M | 101.10%14M | -145.58%-1.56B | -142.64%-1.27B | 236.75%3.42B | 224.29%2.98B | -98.89%-2.5B |
Net cash from operations | 2.08%5.7B | -23.11%11.5B | -18.74%5.58B | 21.20%14.96B | 4.38%6.87B | -16.45%12.34B | -9.42%6.58B | 46.78%14.77B | 77.86%7.26B | 6.14%10.06B |
Cash flow from investment activities | ||||||||||
Interest received - investment | 100.00%656M | 307.25%843M | 455.93%328M | 444.74%207M | 180.95%59M | -32.14%38M | -34.38%21M | -42.27%56M | -38.46%32M | 61.67%97M |
Dividend received - investment | ---- | -12.50%21M | -12.50%21M | --24M | --24M | ---- | ---- | ---- | ---- | ---- |
Decrease in deposits (increase) | 523.20%8.12B | -966.52%-4.81B | -74.84%-1.92B | -113.77%-451M | -186.51%-1.1B | 156.00%3.28B | 140.08%1.27B | -145.39%-5.85B | -7.88%-3.16B | 48.40%-2.38B |
Purchase of fixed assets | -24.44%-784M | -7.94%-1.39B | -2.27%-630M | -20.00%-1.28B | 14.44%-616M | 20.80%-1.07B | -13.03%-720M | -23.83%-1.35B | -25.39%-637M | -26.86%-1.09B |
Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --41M |
Recovery of cash from investments | ---- | ---- | ---- | ---- | ---- | ---- | --79M | ---- | ---- | ---- |
Cash on investment | -108.84%-4.42B | -185.16%-1.46B | -160.15%-2.12B | -19.35%-512M | -46.75%-813M | -11.72%-429M | -81.64%-554M | 39.43%-384M | -134.62%-305M | -111.33%-634M |
Other items in the investment business | ---- | 58.86%502M | 266.89%1.11B | -31.45%316M | --302M | 880.85%461M | ---- | -90.33%47M | -220.00%-160M | 23.66%486M |
Net cash from investment operations | 211.42%3.57B | -270.00%-6.29B | -49.74%-3.21B | -174.69%-1.7B | -2,377.66%-2.14B | 130.42%2.28B | 102.22%94M | -114.69%-7.48B | -20.01%-4.23B | 34.58%-3.49B |
Net cash before financing | 290.27%9.27B | -60.70%5.21B | -49.76%2.38B | -9.30%13.26B | -29.17%4.73B | 100.58%14.62B | 120.26%6.67B | 10.80%7.29B | 444.96%3.03B | 58.37%6.58B |
Cash flow from financing activities | ||||||||||
Refund | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 4.74%-744M |
Interest paid - financing | 6.67%-28M | 13.24%-59M | 16.67%-30M | 13.92%-68M | 12.20%-36M | 11.24%-79M | 10.87%-41M | 11.00%-89M | -318.18%-46M | -138.10%-100M |
Dividends paid - financing | -5.89%-4.92B | -6.74%-10.32B | 12.50%-4.65B | 16.15%-9.67B | 5.46%-5.31B | -65.07%-11.53B | -142.87%-5.62B | -20.71%-6.98B | -23.61%-2.31B | -6.60%-5.79B |
Absorb investment income | ---- | ---- | ---- | --85M | ---- | ---- | ---- | ---- | ---- | ---- |
Other items of the financing business | -33.33%-60M | -36.54%-568M | 41.56%-45M | 44.75%-416M | 78.90%-77M | -538.14%-753M | -630.00%-365M | 67.76%-118M | -21.95%-50M | -36.06%-366M |
Net cash from financing operations | -5.37%-5.14B | -8.45%-11.25B | 12.53%-4.88B | 18.12%-10.37B | 9.78%-5.58B | -69.51%-12.67B | -142.47%-6.18B | -4.47%-7.47B | 9.80%-2.55B | -9.74%-7.15B |
Effect of rate | 33.33%-6M | 73.91%-6M | 25.00%-9M | -355.56%-23M | -340.00%-12M | -65.38%9M | --5M | --26M | ---- | ---- |
Net Cash | 264.86%4.13B | -309.50%-6.04B | -194.24%-2.5B | 48.07%2.88B | -273.32%-851M | 1,141.18%1.95B | 2.29%491M | 67.59%-187M | 121.14%480M | 75.61%-577M |
Begining period cash | -39.63%9.21B | 23.07%15.26B | 23.07%15.26B | 18.73%12.4B | 18.73%12.4B | -1.52%10.44B | -1.52%10.44B | -5.16%10.6B | -5.16%10.6B | -17.47%11.18B |
Cash at the end | 4.62%13.33B | -39.63%9.21B | 10.49%12.75B | 23.07%15.26B | 5.46%11.54B | 18.73%12.4B | -1.31%10.94B | -1.52%10.44B | 24.40%11.08B | -5.16%10.6B |
Cash balance analysis | ||||||||||
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.